Plain-English translation of NCT07458074 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
MIRAMACS is a large Italian research study that collects information about patients who receive continuous-flow mechanical heart pump devices (also called ventricular assist devices or VADs) to treat advanced heart failure. The study tracks how many patients survive, what complications they experience, and how they do over five years after receiving the device. By gathering data from hospitals across Italy, researchers hope to better understand which patients benefit most from this treatment and how to improve outcomes.
Many patients with severe heart failure don't respond to medications alone and need mechanical support to help their heart pump blood. This study exists to create a detailed picture of how well these heart pump devices work in real patients, what problems can occur, and how to provide better care and follow-up for people who receive them.
You likely qualify if…
You likely don't qualify if…
If you participate, your medical information will be collected and stored in a secure research database — this includes details about your condition before surgery, the device implantation procedure, your recovery, and your long-term follow-up care. The study includes both information from the past (dating back to 2010) and ongoing monitoring of new patients, so you may be asked to share records from your doctors or participate in periodic check-ins. Your participation helps researchers understand how well these life-saving devices work and how to improve care for future patients.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Italy